IDEX announces acquisition of ERC

NewsGuard 100/100 Score

IDEX Corporation (NYSE: IEX) announced today that it has acquired ERC from MH Capital Partners II, L.P. ("MH Capital"). ERC is a leader in the manufacture of gas liquid separations and detection solutions for the life science, analytical instrumentation and clinical chemistry markets.

ERC's pioneering products include in-line membrane vacuum degassing solutions, refractive index detectors and ozone generation systems. ERC's original equipment degassing solutions are considered the "standard" for many of the world's leading instrument producers. Located in Kawaguchi, Japan, ERC has a global customer base and annual revenues of approximately ¥2.14 billion. ERC will operate within IDEX's Health and Science Technologies segment. With cash consideration of approximately ¥1.65 billion, ERC is expected to be accretive to IDEX's earnings within the first full year after acquisition.

Commenting on the acquisition, IDEX Chairman and Chief Executive Officer Andrew Silvernail stated, "We are thrilled with the opportunity to add ERC to our Health and Science Technologies platform. ERC provides IDEX with access to key analytical instrumentation customers, a strong manufacturing base in Japan, vital products for clinical diagnostic applications and a gateway to the burgeoning instrumentation markets of Asia. We look forward to significant collaboration in the critical areas of new product design, global sourcing and manufacturing, as we realize strategic account management and operating synergies. We believe ERC affords IDEX Health and Science a unique opportunity to strengthen our product offering for current customers as well as providing access to new and influential market participants." ERC President, Yoshio Ishii, added, "we believe the chance to join IDEX's Health and Science Technologies segment and their global family of brands is a great opportunity for our customers, suppliers and employees. IDEX's commitment to the instrumentation market is well established, and we look forward to working together to achieve continued growth and success in this marketplace."

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
MGI Unveils Comprehensive Expansion of Automation Product Lines for Life Science and Healthcare Research